Ledger.Open graph →
SEC Form D · filed March 18, 2019

OCULAR THERAPEUTIX, INC

Offering
$37.5M
Sold
$37.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BEDFORD, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

W. J. O'Shea · Waltham, MADirectorRichard L. Lindstrom · San Diego, CADirectorCharles A. Warden · Redwood City, CADirectorKevin Hanley · Bedford, MAExecMichael Goldstein · Purchase, NYExecAmarpreet Sawhney · Waltham, MADirectorDaniel Bollag · Bedford, MAExecJeffrey S. Heier · Waltham, MADirectorAntony Mattessich · Bedford, MAExec · DirectorDonald Notman · Montreal, Quebec, CanadaExecJaswinder Chadha · BERKELEY HEIGHTS, NJDirectorBruce A. Peacock · Waltham, MADirectorW. J. O'Shea · Brighton, MADirectorKevin Hanley · Bedford, MAExecRichard L. Lindstrom · Roanoke, VADirectorMichael Goldstein · Purchase, NYExecAmarpreet Sawhney · Waltham, MADirectorDaniel Bollag · Bedford, MAExecJeffrey S. Heier · Waltham, MADirectorAntony Mattessich · Bedford, MAExec · DirectorDonald Notman · Montreal, Quebec, CanadaExecJaswinder Chadha · BERKELEY HEIGHTS, NJDirectorCharles A. Warden · Waltham, MADirectorBruce A. Peacock · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗